MRI is the mainstay for locoregional imaging assessment in rectal cancer. In light of the introduction of neoadjuvant therapies, such as total neoadjuvant treatment (TNT) and organ-preserving treatment for complete responders after TNT, accurate restaging is pivotal. This paper reviews the main MRI features for near-complete and complete responses after TNT and elaborates on the recently published rectal cancer MR imaging ESGAR guidelines.
Adequate restaging after TNT in rectal cancer: pitfalls in radiological (or MRI) assessment
Crimi, Filippo
;Quaia, Emilio;
2026
Abstract
MRI is the mainstay for locoregional imaging assessment in rectal cancer. In light of the introduction of neoadjuvant therapies, such as total neoadjuvant treatment (TNT) and organ-preserving treatment for complete responders after TNT, accurate restaging is pivotal. This paper reviews the main MRI features for near-complete and complete responses after TNT and elaborates on the recently published rectal cancer MR imaging ESGAR guidelines.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS074879832600750X.pdf
accesso aperto
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Creative commons
Dimensione
6.77 MB
Formato
Adobe PDF
|
6.77 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
